Key Market Indicators
Sales of beta blocking medicines in New Zealand are projected to drop 17.8% to around $1.4 million by 2026. Since 1998, the New Zealand market has declined by an average of 4.9% each year. In 2021, it was the 24th largest market in the world, just behind Estonia, which had sales of $4.3 million. Italy, Canada and Australia followed in second, third and fourth place respectively.
